Irritable Bowel Syndrome with Diarrhea Drugs Market

Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.

IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit.

In Irritable Bowel Syndrome with Diarrhea Drugs Market , we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D).

Irritable Bowel Syndrome with Diarrhea Drugs Market contains market size and forecasts of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in global, including the following market information:

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs companies in 2021 (%)

The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at 1428.3 million in 2021 and is projected to reach US$ 2826.1 million by 2028, at a CAGR of 10.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

XIFAXAN Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs include Bausch Health, Allergan, Sebela Pharmaceuticals, Astellas Pharmaceuticals, Amneal Pharms and Pharscin Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, by Type, 2021 (%)

XIFAXAN

Viberzi

Lotronex

Other

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, by Sales Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, by Sales Channel, 2021 (%)

Hospitals Pharmacy

Retail Pharmacy

Other

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues share in global market, 2021 (%)

Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bausch Health

Allergan

Sebela Pharmaceuticals

Astellas Pharmaceuticals

Amneal Pharms

Pharscin Pharma